ArticleRespirology case reports2022
Cavitary pulmonary lesions following emerging lophomoniasis: A novel perspective.
Article in Respirology case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 12 citations in OpenAlex.
- Development and Validation of In-House Conventional and Multiplex PCR Methods for the Detection and Identification of Lophomonas spp.: An Innovative Approach.Journal of clinical laboratory analysis · 2025Article
- First Report of the Pulmonary ParasiteAdvanced biomedical research · 2025Article
- Imaging patterns of Lophomonas blattarum infection in the respiratory tract: a registry-based analysis.BMC infectious diseases · 2024Article
- Severe lophomoniasis in a patient with diabetes and past history of COVID-19 in Central Iran: case report.The Journal of international medical research · 2024Article
- Case series of complicated bronchopulmonary lophomoniasis. Differential diagnosis of tuberculosis?European clinical respiratory journal · 2024Article
- Ruptured pulmonary hydatid cyst and lophomoniasis comorbidity in a young man: a rare case.Oxford medical case reports · 2023Article
- Molecular proof forRespirology case reports · 2022Article
- Article
- Cavitary pulmonary lesions following emerging lophomoniasis: A novel perspective.Respirology case reports · 2022Article
- Fiberoptic Bronchoscopic Findings in Patients Suffering from Emerging Pulmonary Lophomoniasis: A First Registry-Based Clinical Study.Interdisciplinary perspectives on infectious diseases · 2022Article
- Molecular Evidence of Emerged Pulmonary Lophomoniasis due toInterdisciplinary perspectives on infectious diseases · 2022Article
- Detection ofSAGE open medical case reports · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this article, we report a patient referred to the clinic of Imam Khomeini Hospital in Sari, Mazandaran, northern Iran, with a 3-month complaint of chronic cough and weight loss. According to the chest computed tomography scan, a cavity was detected in the upper lobe of the patient's left lung. The patient had no history of smoking or underlying diseases that predisposed him to cavitation, including tuberculosis. Then, bronchoscopy was performed for the patient, and bronchoalveolar lavage fluid was sent to the Iranian National Registry Center for lophomoniasis, and
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.